47 related articles for article (PubMed ID: 26879206)
21. Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation.
Lee Y; Kim JM; Lee EJ
J Endocrinol; 2008 Nov; 199(2):191-9. PubMed ID: 18753332
[TBL] [Abstract][Full Text] [Related]
22. Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells.
Wang Y; Liang WC; Pan WL; Law WK; Hu JS; Ip DT; Waye MM; Ng TB; Wan DC
Phytomedicine; 2014 Sep; 21(11):1310-7. PubMed ID: 25172795
[TBL] [Abstract][Full Text] [Related]
23. Spatiotemporal CCR1, CCL3(MIP-1α), CXCR4, CXCL12(SDF-1α) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain.
Knerlich-Lukoschus F; von der Ropp-Brenner B; Lucius R; Mehdorn HM; Held-Feindt J
J Neurosurg Spine; 2011 May; 14(5):583-97. PubMed ID: 21332278
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharide Promotes Choroidal Neovascularization by Up-Regulation of CXCR4 and CXCR7 Expression in Choroid Endothelial Cell.
Feng YF; Guo H; Yuan F; Shen MQ
PLoS One; 2015; 10(8):e0136175. PubMed ID: 26288180
[TBL] [Abstract][Full Text] [Related]
25. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer.
Masuda T; Nakashima Y; Ando K; Yoshinaga K; Saeki H; Oki E; Morita M; Oda Y; Maehara Y
Anticancer Res; 2014 Nov; 34(11):6397-403. PubMed ID: 25368239
[TBL] [Abstract][Full Text] [Related]
26. Synthetic chemokines directly labeled with a fluorescent dye as tools for studying chemokine and chemokine receptor interactions.
Strong AE; Thierry AC; Cousin P; Moulon C; Demotz S
Eur Cytokine Netw; 2006 Mar; 17(1):49-59. PubMed ID: 16613763
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of CXCR4 in tracheal epithelial cells promotes their proliferation and migration to a stromal cell-derived factor-1 gradient.
Liu J; Yang X; Shi W
Exp Biol Med (Maywood); 2013 Feb; 238(2):144-50. PubMed ID: 23576796
[TBL] [Abstract][Full Text] [Related]
28. A cellular screening assay using analysis of metal-modified fluorescence lifetime.
Cade NI; Fruhwirth G; Archibald SJ; Ng T; Richards D
Biophys J; 2010 Jun; 98(11):2752-7. PubMed ID: 20513420
[TBL] [Abstract][Full Text] [Related]
29. Fluorophore labeling enables imaging and evaluation of specific CXCR4-ligand interaction at the cell membrane for fluorescence-based screening.
Nomura W; Tanabe Y; Tsutsumi H; Tanaka T; Ohba K; Yamamoto N; Tamamura H
Bioconjug Chem; 2008 Sep; 19(9):1917-20. PubMed ID: 18707146
[TBL] [Abstract][Full Text] [Related]
30. Towards personalized antibody cancer therapy: development of a microfluidic cell culture device for antibody selection.
Condelipes PGM; Fontes PM; Godinho-Santos A; Brás EJS; Marques V; Afonso MB; Rodrigues CMP; Chu V; Gonçalves J; Conde JP
Lab Chip; 2022 Nov; 22(23):4717-4728. PubMed ID: 36349999
[TBL] [Abstract][Full Text] [Related]
31. A two-color fluorescence enhanced dot-blot assay for revealing co-operative expression of chemokine receptors in cells.
Khan NU; He H; Wang X; Ge B; Wang Q; Liu X; Lao J; Wang Y; Li J; Wang Z; Zhou S; Huang F
Chem Commun (Camb); 2018 Jan; 54(7):778-781. PubMed ID: 29308791
[TBL] [Abstract][Full Text] [Related]
32. Proteolytic processing of human serum albumin generates EPI-X4, an endogenous antagonist of CXCR4.
Zirafi O; Hermann PC; Münch J
J Leukoc Biol; 2016 Jun; 99(6):863-8. PubMed ID: 26965637
[TBL] [Abstract][Full Text] [Related]
33. Molecular Pharmacology of Chemokine Receptors.
de Wit RH; de Munnik SM; Leurs R; Vischer HF; Smit MJ
Methods Enzymol; 2016; 570():457-515. PubMed ID: 26921959
[TBL] [Abstract][Full Text] [Related]
34. Bio-inspired optical structures for enhancing luminescence.
Zhang Z; Vogelbacher F; Song Y; Tian Y; Li M
Exploration (Beijing); 2023 Aug; 3(4):20220052. PubMed ID: 37933238
[TBL] [Abstract][Full Text] [Related]
35. An Ultra-High Fluorescence Enhancement and High Throughput Assay for Revealing Expression and Internalization of Chemokine Receptor CXCR4.
He H; Wang X; Cheng T; Xia Y; Lao J; Ge B; Ren H; Khan NU; Huang F
Chemistry; 2016 Apr; 22(17):5863-7. PubMed ID: 26879206
[TBL] [Abstract][Full Text] [Related]
36. Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal alpha-helix of SDF-1alpha plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity.
Tan Y; Du J; Cai S; Li X; Ma W; Guo Z; Chen H; Huang Z; Xiao J; Cai L; Cai S
Exp Hematol; 2006 Nov; 34(11):1553-62. PubMed ID: 17046575
[TBL] [Abstract][Full Text] [Related]
37. Detecting Cell Surface Expression of the G Protein-Coupled Receptor CXCR4.
Nevins AM; Marchese A
Methods Mol Biol; 2018; 1722():151-164. PubMed ID: 29264804
[TBL] [Abstract][Full Text] [Related]
38. Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches.
Xu L; Li Y; Sun H; Li D; Hou T
Mol Biosyst; 2013 Aug; 9(8):2107-17. PubMed ID: 23702796
[TBL] [Abstract][Full Text] [Related]
39. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
40. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
